U.S., March 25 -- ClinicalTrials.gov registry received information related to the study (NCT07491367) titled 'Pilot Exploration of Platelet Characterization of Platelet Rich Plasma Created by Two Different Systems' on Feb. 25.
Brief Summary: The investigators would like to study the differences in the quality of Platelet Rich Plasma (PRP) between two different machines in those with knee osteoarthritis. Knee osteoarthritis means your cartilage has been worn down, and it affects your knee joint. Both machines, the APEX Biologix XCELL PRP System and the Emcyte PurePRP Supraphysiologic Concentrating System, are FDA approved, commercially available, and makes PRP. The investigators will check if the platelets in the PRP have different amounts ...